Related references
Note: Only part of the references are listed.Neuroanatomical background and functional considerations for stereotactic interventions in the H fields of Forel
Clemens Neudorfer et al.
BRAIN STRUCTURE & FUNCTION (2018)
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers
Antonio P. Strafella et al.
MOVEMENT DISORDERS (2017)
Mapping the distribution of serotonin transporter in the human brainstem with high-resolution PET: Validation using postmortem autoradiography data
P. Fazio et al.
NEUROIMAGE (2016)
Brain Region-Specific Trafficking of the Dopamine Transporter
Ethan R. Block et al.
JOURNAL OF NEUROSCIENCE (2015)
Quantitative Analysis of 18F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4′-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease
Patrik Fazio et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
The pathomechanisms underlying Parkinson's disease
Kurt A. Jellinger
EXPERT REVIEW OF NEUROTHERAPEUTICS (2014)
Validation of Midbrain Positron Emission Tomography Measures for Nigrostriatal Neurons in Macaques
Christopher A. Brown et al.
ANNALS OF NEUROLOGY (2013)
Validation of nigrostriatal positron emission tomography measures: Critical limits
Morvarid Karimi et al.
ANNALS OF NEUROLOGY (2013)
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease
Jeffrey H. Kordower et al.
BRAIN (2013)
Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT
Martin Schain et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Low nigrostriatal reserve for motor parkinsonism in nonhuman primates
Samer D. Tabbal et al.
EXPERIMENTAL NEUROLOGY (2012)
Quantification of Dopamine Transporter in Human Brain Using PET with 18F-FE-PE2I
Takeshi Sasaki et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Quantification of serotonin transporter availability with [11C]MADAM - A comparison between the ECAT HRRT and HR systems
Martin Schain et al.
NEUROIMAGE (2012)
Advances in imaging in Parkinson's disease
A. Jon Stoessl et al.
LANCET NEUROLOGY (2011)
Clinical Progression in Parkinson Disease and the Neurobiology of Axons
Hsiao-Chun Cheng et al.
ANNALS OF NEUROLOGY (2010)
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Jacqueline Burre et al.
SCIENCE (2010)
Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter
Magnus Schou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
In Vitro Autoradiography and In Vivo Evaluation in Cynomolgus Monkey of [18F]FE-PE2I, a New Dopamine Transporter PET Radioligand
Andrea Varrone et al.
SYNAPSE (2009)
Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinsons disease
Satoshi Orimo et al.
BRAIN (2008)
A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 and [11C]WAY 100635
Zsolt Cselenyi et al.
NEUROIMAGE (2006)
The primate thalamus is a key target for brain dopamine
MA Sánchez-González et al.
JOURNAL OF NEUROSCIENCE (2005)
(123I) β-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome -: Unmasking an early diagnosis
DL Jennings et al.
ARCHIVES OF NEUROLOGY (2004)
Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum
D Martinez et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
[123I]β-CIT SPECT imaging assessment of the rate of Parkinson's disease progression
K Marek et al.
NEUROLOGY (2001)
Dopaminergic innervation of human basal ganglia
L Prensa et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2000)
Share Paper
